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Jeffrey J. Goldberger, MD, Daniel C. Lee, MDSEE PAGE 414S udden cardiac arrest (SCA) is one of the moststriking clinical presentations of cardiovasculardisease. An estimated 234,000 to 326,000 SCAs
occur in the United States each year (1). Unfortu-
nately, mortality for out-of-hospital SCA remains
high, with only 10.6% of patients surviving to hospi-
tal discharge. In patients who reach the hospital, a
rapid multidisciplinary approach is initiated to
preserve neurological function, identify and treat
the underlying cause of SCA, and prevent future
occurrences.
Approximately 38% of these patients will have
obvious noncardiac causes of SCA, such as pulmonary
embolism, primary respiratory failure, drug/medica-
tion intoxication, acidemia, or aneurysmal subarach-
noid hemorrhage. In the remaining patients, up to 48%
may have coronary artery occlusion (2). The electro-
cardiogram (ECG) is one of the ﬁrst tests performed in
these patients; however, 26% of patients without chest
pain or ST-segment elevation can have an acute coro-
nary artery occlusion. Because of the high prevalence
of acute coronary artery occlusions in resuscitated
patients with SCA and the suboptimal detection by
ECG, the 2010 American Heart Association Guidelines
for Cardiopulmonary Resuscitation and Emergency
Cardiovascular Care recommend immediate angiog-
raphy and percutaneous coronary intervention as a
component of post–cardiac arrest protocols (3).
After patient stabilization, initiation of cooling to
protect neurological function, and coronary angiog-
raphy to identify and treat acute coronary occlusion,
the evaluation turns to more chronic cardiac condi-
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tural (e.g., idiopathic dilated cardiomyopathy, hy-
pertrophic cardiomyopathy [HCM], arrhythmogenic
right ventricular cardiomyopathy, cardiac sarcoid-
osis, cardiac amyloidosis, myocarditis) or primary
electrical abnormalities (e.g., long QT syndrome,
Brugada syndrome, catecholaminergic polymorphic
ventricular tachycardia, rarely Wolff-Parkinson-
White syndrome).
Echocardiography remains the most commonly
used imaging modality to identify structural abnor-
malities due to its wide availability, lower cost rela-
tive to cardiac magnetic resonance (CMR) and cardiac
computed tomography, and ability to accurately di-
agnose many of the common cardiac abnormalities
contributing to SCA. However, the cause of SCA
remains uncertain in many patients even after echo-
cardiography and coronary angiography.In this issue of iJACC, Neilan et al. (4) present a
2-center experience of CMR in patients with SCA eti-
ology that was uncertain after such a workup. They
retrospectively identiﬁed 137 patients who presented
with SCA over a 6-year period and underwent CMR to
better elucidate the cause of SCA after a workup that
included clinical history, ECG, echocardiography, and
coronary angiography did not reveal a clear etiology
for SCA. The CMR protocol consisted of cine images
for cardiac function and late gadolinium enhance-
ment (LGE) for identiﬁcation and quantiﬁcation of
myocardial ﬁbrosis. The investigators also character-
ized the pattern of LGE, which could be used to infer
the etiology of myocardial ﬁbrosis. Indeed, in the
current study, CMR identiﬁed a potential arrhythmic
substrate in 104 of 137 patients (76%). The diagnoses
were based upon LGE in a pattern of myocardial
infarction (MI), non-MI LGE, myocarditis, HCM,
sarcoidosis, and arrhythmogenic right ventricular car-
diomyopathy. Over a median follow up of 29 months
(range 18 to 43 months), 16 patients (12%) died and
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42547 patients (34%) experienced appropriate implant-
able cardioverter-deﬁbrillator shock. On multivariable
analysis, the strongest predictor of events was the
presence of LGE and the extent of LGE.
The retrospective nature of this study somewhat
limits the generalizability of these ﬁndings, as noted
by the researchers. Patients with SCA at the 2 centers
were treated according to clinical routine, not a
standardized protocol. The total number of patients
experiencing SCA during the study time frame was
not reported; thus, the proportion of all patients with
SCA who did not undergo CMR either because the
etiology for SCA was clear or it was not ordered for
other reasons is unknown. In these patients, the re-
sults of the diagnostic workup and prognosis were
also not described. Nevertheless, the results of this
study are useful in establishing the diagnostic abili-
ties of CMR in patients with a routine clinical workup
that is unrevealing. The American Heart Association
Guidelines for Management of Patients With Ven-
tricular Arrhythmias and the Prevention of Sudden
Cardiac Death give CMR a Class IIa recommendation
for “when echocardiography does not provide accu-
rate assessment of LV and RV function, and/or eval-
uation of structural changes.”
LGE in a pattern of MI was found in 49 of 137 pa-
tients (36%) who had an unrevealing coronary
angiogram and echocardiogram. An apparent is-
chemic LGE pattern, even after severe coronary artery
disease was excluded by coronary angiography, has
also been reported in patients with a clinical diagnosis
of idiopathic dilated cardiomyopathy (5). Establishing
this etiology has both diagnostic and therapeutic
signiﬁcance. An additional 26 of 137 patients (19%)
had LGE in a noninfarct pattern that could sometimes
be attributed to myocarditis, HCM, or sarcoidosis.
Again, delineation of these etiologies has both diag-
nostic and therapeutic signiﬁcance. Furthermore, the
presence of LGE, irrespective of its origin, has reliably
been shown in multiple studies to confer a higher risk
of ventricular arrhythmia and adverse cardiovascular
events (6). With the further reﬁnement and applica-
tion of new techniques such as T2 mapping to quan-
tify myocardial edema and T1 mapping to quantify
diffuse myocardial ﬁbrosis, the ability of CMR to
interrogate the myocardial substrate for ventricular
arrhythmia is likely to be further enhanced.
Given the observational nature of this study, it
is unknown what impact CMR had on patient man-
agement. Although all of these patients received
implantable cardioverter-deﬁbrillators, an appro-
priate measure by guidelines and in light of the high
rate of subsequent cardiac events, medical manage-
ment targeted toward speciﬁc diagnoses would likelydiffer based on the CMR results. For example, in
those with LGE in a pattern of MI, secondary pre-
vention of coronary heart disease would be initiated.
Identiﬁcation of systemic diseases such as sarcoidosis
and amyloidosis would lead to disease-speciﬁc ther-
apy. Screening of family members in patients diag-
nosed with HCM may lead to earlier diagnosis and
preventive strategies. In patients with preserved left
ventricular function and normal echocardiograms,
electrophysiology studies may potentially have been
avoided in patients with CMR-based diagnoses that
are known substrates for SCA who would otherwise
have been labeled as SCA in a structurally normal
heart.
In patients with new-onset heart failure who
were free of angina, LGE-CMR has been evaluated
as a gatekeeper to invasive coronary angiography,
enabling accurate characterization of the underlying
cause of heart failure (7). Figure 2 of Assomull et al.
(7) illustrates how myocardial tissue characterization
by CMR complements coronary anatomic information
from angiography to provide a more nuanced under-
standing of heart failure etiology in each patient.
Whether CMR could be employed earlier in the diag-
nostic workup of SCA—instead of echocardiography
after exclusion of signiﬁcant coronary artery disease
by coronary angiography—remains unanswered. If a
large proportion of patients had both an echocardio-
gram and CMR, a CMR-only strategy could be cost
effective. However, it is difﬁcult to speculate without
knowing more about the patients who did not un-
dergo CMR. There may also be some limitations to
more widespread CMR use. Local expertise in CMR
may be lacking and CMR may be difﬁcult to perform
in some post-SCA patients due to clinical instability
and/or residual neurological impairment.
In summary, CMR provides an exquisitely detailed
evaluation of the myocardial substrate for ventricular
arrhythmia. In patients surviving SCA, this informa-
tion can be critical for further management. If
feasible, the use of CMR in the early part of the
diagnostic workup for patients with aborted SCA
should be strongly considered, particularly when the
etiology of SCA has not been identiﬁed by the inter-
current workup. Further studies are needed to
determine the most cost-effective strategy for imag-
ing survivors of SCA.
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